2009 - Fellow of the American Statistical Association (ASA)
The scientist’s investigation covers issues in Internal medicine, Surgery, Oncology, Endocrinology and Gastroenterology. The concepts of his Internal medicine study are interwoven with issues in Diabetes mellitus and Pathology. His studies examine the connections between Surgery and genetics, as well as such issues in Cancer, with regards to Loss of heterozygosity.
His study in the field of Induction chemotherapy is also linked to topics like In patient. The Endocrinology study combines topics in areas such as Maternal hypothyroidism, Birth weight and Inflammatory bowel disease. His research in Gastroenterology intersects with topics in Irinotecan, Neutropenia, Toxicity, Proctocolectomy and Genotype.
Theodore Karrison focuses on Internal medicine, Oncology, Surgery, Gastroenterology and Cancer research. His research combines Endocrinology and Internal medicine. In Oncology, he works on issues like Cancer, which are connected to Toxicity.
He works on Surgery which deals in particular with Prospective cohort study. His Gastroenterology study combines topics from a wide range of disciplines, such as Irinotecan and Neutropenia. His Irinotecan research integrates issues from Tolerability, Genotype and Dosing.
Internal medicine, Oncology, Gastroenterology, Pembrolizumab and Randomized controlled trial are his primary areas of study. Theodore Karrison applies his multidisciplinary studies on Internal medicine and In patient in his research. The various areas that Theodore Karrison examines in his Oncology study include Androgen deprivation therapy, Prostate cancer, Ipilimumab, Immunotherapy and Radiation therapy.
The study incorporates disciplines such as Oxaliplatin, Anastomosis and Cohort in addition to Gastroenterology. The concepts of his Pembrolizumab study are interwoven with issues in Previously treated and Mesothelioma. He interconnects Tocilizumab, Low dose and Confidence interval in the investigation of issues within Randomized controlled trial.
His primary scientific interests are in Internal medicine, Oncology, Pembrolizumab, Randomized controlled trial and Gastroenterology. His research related to Interquartile range, Clinical endpoint, Lymph node, Androgen deprivation therapy and Salvage radiotherapy might be considered part of Internal medicine. His research integrates issues of Cancer, Human Papillomavirus Positive, Immunotherapy, Disease and De-escalation in his study of Oncology.
His research in Pembrolizumab intersects with topics in Previously treated, Mesothelioma, Biopsy, Melanoma and Ipilimumab. His Randomized controlled trial research is multidisciplinary, incorporating elements of Tocilizumab, Low dose, Phases of clinical research and Premature birth. His study in Gastroenterology is interdisciplinary in nature, drawing from both Irinotecan, Oxaliplatin, Retrospective cohort study, Colon surgery and Cohort.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan.
Federico Innocenti;Samir D. Undevia;Lalitha Iyer;Pei Xian Chen.
Journal of Clinical Oncology (2004)
UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity
L Iyer;S Das;L Janisch;M Wen.
Pharmacogenomics Journal (2002)
Critical Evaluation of Diagnostic Aids for the Detection of Oral Cancer
Mark W. Lingen;John R. Kalmar;Theodore Karrison;Paul M. Speight.
Oral Oncology (2008)
Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series.
Sonali M. Smith;Michelle M. Le Beau;Dezheng Huo;Theodore Karrison.
Phase II Trial of Bevacizumab Plus Gemcitabine in Patients With Advanced Pancreatic Cancer
Hedy L. Kindler;Gregory Friberg;Deepti A. Singh;Gershon Locker.
Journal of Clinical Oncology (2005)
Quantitative study of insulin secretion and clearance in normal and obese subjects.
K S Polonsky;B D Given;L Hirsch;E T Shapiro.
Journal of Clinical Investigation (1988)
Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus.
D A Ehrmann;J Sturis;M M Byrne;T Karrison.
Journal of Clinical Investigation (1995)
Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997.
Mark Haas;Shane M. Meehan;Theodore G. Karrison;Benjamin H. Spargo.
American Journal of Kidney Diseases (1997)
Dormancy of Mammary Carcinoma After Mastectomy
Theodore G. Karrison;Donald J. Ferguson;Paul Meier.
Journal of the National Cancer Institute (1999)
Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients.
K S Polonsky;J Licinio-Paixao;B D Given;W Pugh.
Journal of Clinical Investigation (1986)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: